Creating a Risk Profile to Personalize Myeloma Care with Ola Landgren, MD, PhD, University of Miami

Update: 2024-07-15

Description

Dr. Ola Landgren shares a clinical trial about smoldering myeloma. Join the REVIVE trial study for high-risk smoldering myeloma study here.

He also share about his research partnership with HealthTree on a personalized medicine study that creates a computerized model of risk prediction and treatment recommendations for newly diagnosed patients.

This is a study that is open to all myeloma patients regardless of where they are being treated. The only involvement by patients is to sign a consent form and connect their medical records which requires less than 5 minutes of participation.

Comments

In Channel

2025 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

2025-09-0230:12

2025 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

2025-09-0230:12

Minimal Residual Disease (MRD) Testing with Dr. Rafael Fonseca

2025-04-0459:30

Preventing Myeloma Progression with Diet: The Nutrivention-2 Stu

2025-03-0348:27

The Future of Bispecific Antibodies with Dr. Philippe Moreau

2025-02-1257:03

A Look into the 2025 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

2025-02-0158:15

Driving New Discoveries in Myeloma Research with Dr. Brian Van Ness from the University of Minnesota

2024-12-3101:10:53

2024 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

2024-11-0701:09:43

The Latest in Amyloidosis Care and Research with Morie Gertz, MD, Mayo Clinic

2024-07-1836:55

Creating a Risk Profile to Personalize Myeloma Care with Ola Landgren, MD, PhD, University of Miami

2024-07-1501:01:06

Using all the Myeloma Tools in the Toolbox with Clifton Mo, MD, Dana Farber Cancer Institute

2024-03-1258:43

Alfred Garfall, MD and Bea Razzo, MD on Bispecific Antibodies in Multiple Myeloma

2024-02-1059:41

The 2024 Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson

2024-01-0901:15:32

Today's CAR T Options in Multiple Myeloma Care with Luciano Costa, MD, UAB

2023-10-2701:01:57

Multiple myeloma mid-year progress with Dr. Paul Richardson of Dana Farber

2023-09-2201:04:17

Stem Cell Transplant Advances and Use in the Age of Immunotherapy

2023-09-2001:05:18

Essential Research for Myeloma Cures with Faith Davies, NYU

2023-08-3001:08:13

The Utility of MRD Testing for Myeloma Patient Treatment and Outcomes

2023-07-0701:11:04

Understanding Blood-Based Testing in Multiple Myeloma with Ola Landgren, MD, PhD

2023-05-3101:02:02

A New "Moda" Targeting CD38 in Multiple Myeloma with Noa Biran, MD, John Theurer

2023-02-0101:02:37

00:00

Creating a Risk Profile to Personalize Myeloma Care with Ola Landgren, MD, PhD, University of Miami

#box-pro-ellipsis-176098074478850{-webkit-line-clamp:2;}Creating a Risk Profile to Personalize Myeloma Care with Ola Landgren, MD, PhD, University of Miami

Creating a Risk Profile to Personalize Myeloma Care with Ola Landgren, MD, PhD, University of Miami

HealthTree Podcast for MM

Creating a Risk Profile to Personalize Myeloma Care with Ola Landgren, MD, PhD, University of Miami